Letter: Outcomes of Kidney Transplant Recipients Undergoing Percutaneous Coronary Intervention

Abstract

Get full access to this article

View all access options for this article.

References

Ang

Chia

Krittanawong

, et al. Trends, characteristics, and outcomes of percutaneous coronary intervention among kidney transplant recipients. Angiology. Published online March 10, 2026. doi:10.1177/00033197261425811

Zheng

Evans

Dinh

, et al. Clinical outcomes of renal transplant recipients undergoing percutaneous coronary intervention. Heart Lung Circ. 2024;33(7):998-1008.

Lang

Patyna

Büttner

, et al. Incidence, risk factors and prognostic impact of acute kidney injury after coronary angiography and intervention in kidney transplant recipients: a single-center retrospective analysis. Postepy Kardiol Interwencyjnej. 2020;16(1):58-64.

Chawla

Lak

Sammour

, et al. Outcomes of interventional management of coronary artery disease in kidney transplant recipients. Transplant Proc. 2022;54(3):663-670.

Nakao

Yamaguchi

Satomi

, et al. Outcomes of renal transplant recipients after percutaneous coronary intervention. Am J Cardiol. 2020;125(9):1305-1311.

Hansen

Bachmann

Budde

Choi

Calcineurin inhibitor associated nephrotoxicity in kidney transplantation—a transplant nephrologist’s perspective. Acta Physiol (Oxf). 2025;241(5):e70047.

Hoorn

Walsh

McCormick

Zietse

Unwin

Ellison

DH.

Pathogenesis of calcineurin inhibitor-induced hypertension. J Nephrol. 2012;25(3):269-275.

Eberhardt

Nasrullah

Pfeilschifter

Activation of renal profibrotic TGFβ controlled signaling cascades by calcineurin and mTOR inhibitors. Cell Signal. 2018;52:1-11.

Paccagnella

Andreola

Gambaro

Caletti

Immunosuppressive therapy-related cardiovascular risk factors in renal transplantation: a narrative review. Cardiorenal Med. 2025;15(1):209-228. doi:10.1159/000542378

10.

Opałka

Żołnierczuk

Grabowska

Immunosuppressive agents-effects on the cardiovascular system and selected metabolic aspects: a review. J Clin Med. 2023;12(21):6935.

11.

Chia

Ang

SP.

Elevated C-reactive protein and cardiovascular risk. Curr Opin Cardiol. 2025;40(4):237-243.